Immune response, accomodation, and tolerance to transplantation carbohydrate antigens

Transplantation

Volumn 78, Issue 8, 2004, Pages 1093-1098

  Galili, Uri ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

gal epitope; ABO incompatible transplantation; Accommodation; Anti blood group antibodies; Anti Gal antibody; Tolerance

Indexed keywords

ALPHA 1,3 GALACTOSYLTRANSFERASE; BLOOD GROUP A ANTIGEN; BLOOD GROUP B ANTIGEN; CARBOHYDRATE ANTIGEN; EPITOPE; GALACTOSYLGALACTOSE; GALACTOSYLTRANSFERASE; GENE PRODUCT; UNCLASSIFIED DRUG; ANTIGEN; CARBOHYDRATE;

ACCOMMODATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; AUTOLOGOUS BONE MARROW TRANSPLANTATION; B LYMPHOCYTE ACTIVATION; BLOOD GROUP ABO SYSTEM; CELL TRANSPLANTATION; CONTROLLED STUDY; CYTOLYSIS; DISEASE ASSOCIATION; EXPERIMENTAL MODEL; GENE THERAPY; GENETIC INCOMPATIBILITY; GRAFT REJECTION; HELPER CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; WILD TYPE; ANIMAL; HISTOCOMPATIBILITY; HUMAN; IMMUNOLOGY; TRANSPLANTATION TOLERANCE;

ABO BLOOD-GROUP SYSTEM; ANIMALS; ANTIBODY FORMATION; ANTIGENS; CARBOHYDRATES; HISTOCOMPATIBILITY; HUMANS; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION TOLERANCE;

EID: 7044233061     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000142673.32394.95     Document Type: Review

References (58)

1. Lai L, Kolber-Simonds D, Park KW, et al. Production of α-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 2002; 295: 1089.
2. Phelps CJ, Koike C, Vaught TD, et al. Production of α1,3- galactosyltransferase-deficient pigs. Science 2003; 299: 411.
3. Takahashi K. ABO incompatible kidney transplantation. Amsterdam: Elsevier Science 2001.
4. Rydberg L. ABO incompatibility in solid organ transplantation. Transfusion Med 2001; 11: 325.
5. Wu A, Buhler LH, Cooper DK. ABO-incompatible organ and bone marrow transplantation: current status. Transpl Int 2003; 16: 291.
6. Springer GF, Horton RE. Blood group isoantibody stimulation in man by feeding blood group-active bacteria. J Clin Invest 1969; 48: 1280.
7. Starzl TE. Renal homografts in patients with major donor recipient blood group incompatibilities. Surgery 1964; 55: 195.
8. Wilbrandt R, Tung KS, Deodhar SD, et al. ABO blood group incompatibility in human renal homotransplantation. Am J Clin Pathol 1969; 51: 15.
9. Cooper DK. Clinical survey of heart transplantation between ABO blood group-incompatible recipients and donors. J Heart Transplant 1990; 9: 376.
10. Alexandre GP, Squifflet JP, DeBruyere BM, et al. Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc 1987; 19: 4538.
11. Slapak M, Digard N, Ahmed M, et al. Renal transplantation across the ABO barrier-A 9-year experience. Transplant Proc 1990; 22: 1425.
12. Bennett AD, McAlack RF, Raja R, et al. Experience with known ABO-mismatched renal transplants. Transplant Proc 1987; 19: 4543.
13. Mendez R, Sakhrani L, Aswad S, et al. Successful living-related ABO incompatible renal transplant using the BIOSYNSORB. Immunoadsorption Column. Transplant Proc 1992; 24: 1738.
14. Tanabe K, Takahashi K, Sonda K, et al. Long-term results of ABO-incompatible living kidney transplantation: a single-center experience. Transplantation 1998; 65: 224.
15. Yamashita M, Aikawa A, Ohara T, et al. Local immune states in ABO-incompatible renal allografts. Transplant Proc 1993; 25: 274.
16. Aswad S, Mendez R, Mendez RG, et al. Crossing the ABO blood barrier in renal transplantation. Transplant Proc 1993; 25: 267.
17. Karakayali H, Moray G, Demirag A, et al. Long-term follow-up of ABO-incompatible renal transplant recipients. Transplant Proc 1999; 31: 256.
18. Kobayashi T, Yokoyama I, Nagasaka T, et al. Comparative study of antibody removal before pig-to-baboon and human ABO-incompatible renal transplantation. Transplant Proc 2000; 32: 1097.
19. Shishido S, Asanuma H, Tajima E, et al. ABO-incompatible living-donor kidney transplantation in children. Transplantation 2001; 72: 1037.
20. Ishida H, Koyama I, Sawada T, et al. Anti-AB titer changes in patients with ABO incompatibility after living related kidney transplantations: survey of 101 cases to determine whether splenectomies are necessary for successful transplantation. Transplantation 2000; 70: 681.
21. Latinne D, Squifflet JP, De Bruyere M, et al. Subclasses of ABO isoagglutinins in ABO-incompatible kidney transplantation. Transplant Proc 1989; 21: 641.
22. Park WD, Grande JP, Ninova D, et al. Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury. Am J Transplant 2003; 3: 952.
23. Galili U, Anaraki F, Thall A, et al. One percent of circulating B lymphocytes are capable of producing the natural anti-Gal antibody. Blood 1993; 82: 2485.
24. Chopek MW, Simmons RL, Platt JL. ABO-incompatible kidney transplantation: initial immunopathologic evaluation. Transplant Proc 1987; 19: 4553.
25. Platt JL, Bach FH. The barrier to xenotransplantation. Transplantation 1991; 52: 937.
26. Bach FH, Ferran C, Soares M, et al. Modification of vascular responses in xenotransplantation: inflammation and apoptosis. Nat Med 1997; 3: 944.
27. Soares MP, Lin Y, Sato K, et al. Accommodation. Immunol Today 1999; 20: 434.
28. Brouard S, Blancho G, Moreau A, et al. Long-term survival of hamster-to-rat cardiac xenografts in the absence of a Th2 shift. Transplantation 1998; 65: 1555.
29. Suhr BD, Guzman-Paz M, Apasova EP, et al. Induction of accommodation in the hamster-to-rat model requires inhibition of the membrane attack complex of complement. Transplant Proc 2000; 32: 976.
30. Yuzawa Y, Brett J, Fukatsu A, et al. Interaction of antibody with Forssman antigen in guinea pigs. A mechanism of adaptation to antibody- and complement-mediated injury. Am J Pathol 1995; 146: 1260.
31. Hasan R, Van den Bogaerde J, Forty J, et al. Xenograft adaptation is dependent on the presence of antispecies antibody, not prolonged residence in the recipient. Transplant Proc 1992; 24: 531.
32. Mohiuddin MM, Ogawa H, Yin DP, et al. Antibody-mediated accommodation of heart grafts expressing an incompatible carbohydrate antigen. Transplantation 2003; 75: 258.
33. West LJ, Pollock-Barziv SM, Dipchand AI, et al. ABO-incompatible heart transplantation in infants. N Engl J Med 2001; 344: 793.
34. Thall AD, Maly P, Lowe JB. Oocyte Galα1-3Gal epitopes implicated in sperm adhesion to the zona pellucide glycoprotein ZP3 are not required for fertilization in the mouse. J Biol Chem 1995; 270: 21437.
35. Tearle RG, Tange MJ, Zannettino ZL, et al. The α-1,3- galactosyltransferase knockout mouse. Implications for xenotransplantation. Transplantation 1996; 61: 13.
36. Galili U, Shohet SB, Kobrin E, et al. Man, apes, and Old World monkeys differ from other mammals in the expression of α-galactosyl epitopes on nucleated cells. J Biol Chem 1988; 263: 17755.
37. Tanemura M, Yin D, Chong AS, et al. Differential immune responses to α-gal epitopes on xenografts and allografts: implications for accommodation in xenotransplantation. J Clin Invest 2000; 105: 301.
38. Galili U, Rachmilewitz EA, Peleg A, et al. A unique natural human IgG antibody with anti-α-galactosyl specificity. J Exp Med 1984; 160: 1519.
39. Galili, U, Ishida H, Toma K, et al. Anti-Gal A/B, a novel anti-blood group antibody identified in recipients of ABO incompatible kidney allografts. Transplantation 2003; 74: 1574.
40. Galili U, Buehler J, Shohet SB, et al. The human natural anti-Gal IgG. III. The subtlety of immune tolerance in man as demonstrated by cross-reactivity between natural anti-Gal and anti-B antibodies. J Exp Med 1987; 165: 693.
41. McMorrow IM, Comrack CA, Nazarey PP, et al. Relationship between ABO blood group and levels of Galα3Galactose-reactive human immunoglobulin G. Transplantation 1997; 64: 546.
42. Speir JA, Abdel-Motal UM, Jondal M, et al. Crystal structure of an MHC class I presented glycopeptide that generates carbohydrate-specific CTL. Immunity 1999; 10: 51.
43. Pearse MJ, Witort E, Mottram P, et al. Anti-Gal antibody-mediated allograft rejection in α1,3-galactosyltransferase gene knockout mice: a model of delayed xenograft rejection. Transplantation 1998; 66: 748.
44. Rieben R, Korchagina EY, von Allmen E, et al. In vitro evaluation of the efficacy and biocompatibility of new, synthetic ABO immunoabsorbents. Transplantation 1995; 60: 425.
45. Cretin N, Bracy J, Hanson K, et al. The role of T cell help in the production of antibodies specific for Galα1-3Gal. J Immunol 2002; 168: 1479.
46. Ogawa H, Mohiuddin MM, Yin DP, et al. Mouse-heart grafts expressing an incompatible carbohydrate antigen. II. Transition from accommodation to tolerance. Transplantation 2004; 77: 366.
47. Goodnow CC, Brink R, Adams E. Breakdown of self-tolerance in anergic B lymphocytes. Nature 1991; 352: 532.
48. Groth CG, Korsgren O, Tibell A, et al. Transplantation of porcine fetal pancreas to diabetic patients. Lancet 1994; 344: 1402.
49. Galili U, Tibell A, Samuelsson B, et al. Increased anti-Gal activity in diabetic patients transplanted with fetal porcine islet cell clusters. Transplantation 1995; 59: 1549.
50. Young Y-G, deGoma E, Odhan H, et al. Tolerization of anti-Galα1- 3Gal natural antibody-forming B cells by induction of mixed chimerism. J Exp Med 1998; 187: 1335.
51. Ohdan H, Yang YG, Shimizu A, et al. Mixed chimerism induced without lethal conditioning prevents T cell- and anti-Galα1,3Gal-mediated graft rejection. Transplantation 2000; 69: 910.
52. Yin D, Ma L, Varghese A, et al. Intact active bone transplantation synergizes with anti-CD40 ligand therapy to induce B cell tolerance. J Immunol 2002; 168: 5352.
53. Bracy JL, Sachs DH, Iacomini J. Inhibition of xenoreactive natural antibody production by retroviral gene therapy. Science 1998; 28: 1845.
54. Bracy JL, Iacomini J. Induction of B-cell tolerance by retroviral gene therapy. Blood 2000; 96: 3008.
55. Ogawa H, Yin DP, Shen J, et al. Tolerance induction to a mammalian blood group-like carbohydrate antigen by syngeneic lymphocytes expressing the antigen. Blood 2003; 101: 2318.
56. Mohiuddin M, Ogawa H, Yin DP, et al. Tolerance induction to a mammalian blood group like carbohydrate antigen by syngeneic lymphocytes expressing the antigen: II. Tolerance induction on memory B cells. Blood 2003; 102: 229.
57. Ogawa H, Yin DP, Galili U. Induction of immune tolerance to a transplantation carbohydrate antigen by gene therapy with autologous lymphocytes transduced with adenovirus containing the corresponding glycosyltransferase gene. Gene Ther 2004; 11: 292.
58. Yamamoto F, Clausen H, White T, et al. Molecular genetic basis of the histo-blood group ABO system. Nature 1990; 345: 229.